These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9288880

  • 1. Detection of DNA modifications by the 32P-postlabelling assay.
    Phillips DH.
    Mutat Res; 1997 Aug 01; 378(1-2):1-12. PubMed ID: 9288880
    [Abstract] [Full Text] [Related]

  • 2. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K, Liehr JG, Gladek A, Randerath E.
    IARC Sci Publ; 1989 Aug 01; (96):189-205. PubMed ID: 2509347
    [Abstract] [Full Text] [Related]

  • 3. The use of benzo[a]pyrene diolepoxide-modified DNA standards for adduct quantification in 32P-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study.
    Baan RA, Steenwinkel MJ, van Asten S, Roggeband R, van Delft JH.
    Mutat Res; 1997 Aug 01; 378(1-2):41-50. PubMed ID: 9288884
    [Abstract] [Full Text] [Related]

  • 4. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
    Talaska G, Roh JH, Getek T.
    J Chromatogr; 1992 Sep 16; 580(1-2):293-323. PubMed ID: 1400827
    [Abstract] [Full Text] [Related]

  • 5. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K, Anna L, Rudnai P, Schoket B.
    Mutat Res; 2011 Mar 18; 721(1):95-100. PubMed ID: 21237286
    [Abstract] [Full Text] [Related]

  • 6. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K, Randerath E.
    J UOEH; 1989 Mar 20; 11 Suppl():368-86. PubMed ID: 2664950
    [Abstract] [Full Text] [Related]

  • 7. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG, Kato S, Bowman ED, Petruzzelli S, Cooper DP, Povey AC, Weston A.
    IARC Sci Publ; 1993 Mar 20; (124):243-54. PubMed ID: 8225491
    [Abstract] [Full Text] [Related]

  • 8. Development of a 32P-postlabelling method for the detection of 1,N2-propanodeoxyguanosine adducts of crotonaldehyde in vivo.
    Schuler BD, Eder E.
    Arch Toxicol; 2000 Sep 20; 74(7):404-14. PubMed ID: 11043496
    [Abstract] [Full Text] [Related]

  • 9. 32P-postlabeling analysis of DNA adducts.
    Phillips DH, Hewer A, Arlt VM.
    Methods Mol Biol; 2005 Sep 20; 291():3-12. PubMed ID: 15502206
    [Abstract] [Full Text] [Related]

  • 10. ³²P-postlabelling for the sensitive detection of DNA adducts.
    Jones NJ.
    Methods Mol Biol; 2012 Sep 20; 817():183-206. PubMed ID: 22147574
    [Abstract] [Full Text] [Related]

  • 11. Monitoring human exposure to carcinogens by ultrasensitive postlabelling assays: application to unidentified genotoxicants.
    Randerath K, Miller RH, Mittal D, Randerath E.
    IARC Sci Publ; 1988 Sep 20; (89):361-7. PubMed ID: 3198221
    [Abstract] [Full Text] [Related]

  • 12. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
    Talaska G, Dooley KL, Kadlubar FF.
    Carcinogenesis; 1990 Apr 20; 11(4):639-46. PubMed ID: 2323002
    [Abstract] [Full Text] [Related]

  • 13. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K, Randerath E.
    Princess Takamatsu Symp; 1990 Apr 20; 21():317-28. PubMed ID: 2134685
    [Abstract] [Full Text] [Related]

  • 14. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP, Crane AE, Steiner S.
    IARC Sci Publ; 1993 Apr 20; (124):255-62. PubMed ID: 8225493
    [Abstract] [Full Text] [Related]

  • 15. Identification and quantitation of hepatic DNA adducts formed in B6C3F1 mice from 1'-hydroxy-2',3'-dehydroestragole: comparison of the adducts detected with the 1'-3H-labelled carcinogen and by 32P-postlabelling.
    Fennell TR, Juhl U, Miller EC, Miller JA.
    Carcinogenesis; 1986 Nov 20; 7(11):1881-7. PubMed ID: 3769137
    [Abstract] [Full Text] [Related]

  • 16. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV.
    IARC Sci Publ; 1993 Nov 20; (124):25-34. PubMed ID: 8225492
    [Abstract] [Full Text] [Related]

  • 17. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K, Randerath E, Agrawal HP, Reddy MV.
    IARC Sci Publ; 1984 Nov 20; (59):217-31. PubMed ID: 6443609
    [Abstract] [Full Text] [Related]

  • 18. Measurement of DNA adducts in humans after complex mixture exposure.
    Dale CM, Garner RC.
    Food Chem Toxicol; 1996 Sep 20; 34(9):905-19. PubMed ID: 8972883
    [Abstract] [Full Text] [Related]

  • 19. 32P-Postlabeling Analysis of DNA Adducts.
    Phillips DH, Arlt VM.
    Methods Mol Biol; 2020 Sep 20; 2102():291-302. PubMed ID: 31989562
    [Abstract] [Full Text] [Related]

  • 20. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
    Culp SJ, Roberts DW, Talaska G, Lang NP, Fu PP, Lay JO, Teitel CH, Snawder JE, Von Tungeln LS, Kadlubar FF.
    Mutat Res; 1997 Aug 01; 378(1-2):97-112. PubMed ID: 9288889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.